{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:21:30Z","timestamp":1648722090106},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00120-012-2819-4","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T17:21:15Z","timestamp":1331140875000},"page":"348-351","source":"Crossref","is-referenced-by-count":1,"title":["Botulinomtoxin vs. sakrale Neuromodulation bei idiopathischer Detrusor\u00fcberaktivit\u00e4t"],"prefix":"10.1007","volume":"51","author":[{"given":"W.","family":"Leicht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Th\u00fcroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,9]]},"reference":[{"key":"2819_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","volume":"29","author":"Abrams","year":"2010","unstructured":"Abrams P, Andersson KE, Birder L et al (2010) Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 29(1):213\u2013240","journal-title":"Neurourol Urodyn"},{"key":"2819_CR2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49(4):644\u2013650","journal-title":"Eur Urol"},{"key":"2819_CR3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.juro.2008.03.028","volume":"180","author":"Brubaker","year":"2008","unstructured":"Brubaker L, Richter HE, Visco A et al (2008) Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol 180(1):217\u2013222","journal-title":"J Urol"},{"key":"2819_CR4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0022-5347(05)65550-4","volume":"166","author":"Cappellano","year":"2001","unstructured":"Cappellano F, Bertapelle P, Spinelli M et al (2001) Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol 166(6):2277\u20132280","journal-title":"J Urol"},{"key":"2819_CR5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1113\/jphysiol.1976.sp011381","volume":"257","author":"Groat","year":"1976","unstructured":"Groat WC de (1976) Mechanisms underlying recurrent inhibition in the sacral parasympathetic outflow to the urinary bladder. J Physiol 257(2):503\u2013513","journal-title":"J Physiol"},{"key":"2819_CR6","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1016\/j.juro.2009.01.117","volume":"181","author":"Flynn","year":"2009","unstructured":"Flynn MK, Amundsen CL, Perevich M et al (2009) Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol 181(6):2608\u20132615","journal-title":"J Urol"},{"key":"2819_CR7","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-5347(05)00335-6","volume":"175","author":"Groen","year":"2006","unstructured":"Groen J, Ruud Bosch JL, Mastrigt R van (2006) Sacral neuromodulation in women with idiopathic detrusor overactivity incontinence: decreased overactivity but unchanged bladder contraction strength and urethral resistance during voiding. J Urol 175(3 Pt 1):1005\u20131009","journal-title":"J Urol"},{"key":"2819_CR8","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0022-5347(05)67558-1","volume":"163","author":"Hassouna","year":"2000","unstructured":"Hassouna MM, Siegel SW, N\u00ffeholt AA et al (2000) Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol 163(6):1849\u20131854","journal-title":"J Urol"},{"key":"2819_CR9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","volume":"326","author":"Herbison","year":"2003","unstructured":"Herbison P, Hay-Smith J, Ellis G, Moore K (2003) Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ 326(7394):841\u2013844","journal-title":"BMJ"},{"key":"2819_CR10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.urology.2006.03.020","volume":"68","author":"Hijaz","year":"2006","unstructured":"Hijaz A, Vasavada SP, Daneshgari F et al (2006) Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience. Urology 68(3):533\u2013537","journal-title":"Urology"},{"key":"2819_CR11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eururo.2005.12.012","volume":"49","author":"Kalsi","year":"2006","unstructured":"Kalsi V, Apostolidis A, Popat R et al (2006) Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 49(3):528\u2013535","journal-title":"Eur Urol"},{"key":"2819_CR12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2006.10.047","volume":"177","author":"Karsenty","year":"2007","unstructured":"Karsenty G, Elzayat E, Delapparent T et al (2007) Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol 177(3):1011\u20131014","journal-title":"J Urol"},{"key":"2819_CR13","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.eururo.2006.11.011","volume":"51","author":"Kessler","year":"2007","unstructured":"Kessler TM, Buchser E, Meyer S et al (2007) Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland. Eur Urol 51(5):1357\u20131363","journal-title":"Eur Urol"},{"key":"2819_CR14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","volume":"24","author":"Kessler","year":"2005","unstructured":"Kessler TM, Danuser H, Schumacher M et al (2005) Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 24(3):231\u2013236","journal-title":"Neurourol Urodyn"},{"key":"2819_CR15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","volume":"178","author":"Kuo","year":"2007","unstructured":"Kuo HC (2007) Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 178(4 Pt 1):1359\u20131363","journal-title":"J Urol"},{"key":"2819_CR16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","volume":"87","author":"Milsom","year":"2001","unstructured":"Milsom I, Abrams P, Cardozo L et al (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87(9):760\u2013766","journal-title":"BJU Int"},{"key":"2819_CR17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-410X.2005.05725.x","volume":"96","author":"Rajkumar","year":"2005","unstructured":"Rajkumar GN, Small DR, Mustafa AW, Conn G (2005) A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 96(6):848\u2013852","journal-title":"BJU Int"},{"key":"2819_CR18","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.juro.2007.01.130","volume":"177","author":"Sahai","year":"2007","unstructured":"Sahai A, Khan MS, Dasgupta P (2007) Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 177(6):2231\u20132236","journal-title":"J Urol"},{"key":"2819_CR19","first-page":"177","volume":"176","author":"Schmid","year":"2006","unstructured":"Schmid DM, Sauermann P, Werner M et al (2006) Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol. Jul 176(1):177\u2013185","journal-title":"Jul"},{"key":"2819_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1442-2042.2008.02016.x","volume":"15","author":"Schulte-Baukloh","year":"2008","unstructured":"Schulte-Baukloh H, Bigalke H, Miller K et al (2008) Botulinum neurotoxin type A in urology: antibodies as a cause of therapy failure. Int J Urol 15(5):407\u2013415","journal-title":"Int J Urol"},{"key":"2819_CR21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-2004-830203","volume":"36","author":"Schulte-Baukloh","year":"2005","unstructured":"Schulte-Baukloh H, Weiss C, Schobert J et al (2005) Subjective patient satisfaction after injection of botulinum-a toxin in detrusor overactivity. Aktuelle Urol 36(3):230\u2013233","journal-title":"Aktuelle Urol"},{"key":"2819_CR22","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50(6):1306\u20131314","journal-title":"Eur Urol"},{"key":"2819_CR23","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.juro.2007.07.032","volume":"178","author":"Kerrebroeck","year":"2007","unstructured":"Kerrebroeck PE van, Voskuilen AC van, Heesakkers JP et al (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178(5):2029\u20132034","journal-title":"J Urol"},{"key":"2819_CR24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1464-410X.2006.06508.x","volume":"99","author":"Van","year":"2007","unstructured":"Van Voskuilen AC, Oerlemans DJ, Weil EH et al (2007) Medium-term experience of sacral neuromodulation by tined lead implantation. BJU Int 99(1):107\u2013110","journal-title":"BJU Int"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-012-2819-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-012-2819-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-012-2819-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:48:19Z","timestamp":1558626499000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-012-2819-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["2819"],"URL":"https:\/\/doi.org\/10.1007\/s00120-012-2819-4","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}